Print version of this report
TGA Action ID RC-2026-RN-00470-1
Type of Product Medical Device
Product Name/Description HemosIL AcuStar ADAMTS13 Activity. An in vitro diagnostic medical device (IVD).

Part Number: 0009802048

Lot Numbers: B37916, B38144, B40093

Expiry Dates: 2026-09-01, 2026-12-16, 2027-03-01
ARTG Number 191094
Unique Device Identifier (UDI) 08426950602422
Action Type Product Correction
Action Level Hospital
Hazard Classification Class II
Reason for the Action Customer complaints have reported that the HemosIL AcuStar ADAMTS13 Activity assay does not meet its labelled on-board stability claim of 56 days at 2-8°C on the ACL AcuStar system across multiple lots.

Internal testing has demonstrated an increase in measured ADAMTS13 activity at the 10% medical decision level (MDL), with values observed to exceed the established acceptance criteria by up to 0.6%.

An internal investigation has identified a previously unrecognised problem whereby erroneously high patient results may occur after extended on-board use, while quality control results may remain within acceptable limits.
Instructions for Customers/Users Customers should:

1. Identify all stock of this product, particularly if already on-board an ACL AcuStar system.
2. Immediately use the reduced on-board instrument stability claim of 28 days at 2-8°C for all current and future lots of this product.
3. Run quality controls in accordance with the labelled instructions for use.

Note that the on-board instrument stability claim in the Instructions for Use will be updated in future lots of HemosIL AcuStar ADAMTS13 Activity.

Until this update is implemented, lots will be distributed with a sticker indicating the reduced 28-day indicating the reduced 28-day on-board stability claim on the ACL AcuStar system.


This action has been closed out on 27/10/2026
Action Commencement Date 22/06/2026
Responsible Entity Werfen Australia Pty Ltd
Contact Information 1300 369 132 - Sponsor Customer Service